Atlas Trials

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Clinical trial NCT00385125 · UNKNOWN

Trial details

NCT number
NCT00385125
Sponsor
University of Magdeburg
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, High-Grade
Start date
2004-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.